Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOR-CACTUS: Injection versus primary surgery for carpal tunnel syndrome
2021-004756-42Phase 4Active
- Sponsor
- Diakonhjemmet Sykehus
- Start
- Oct 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of triamcinolone hexacetonide in carpal tunnel syndrome (CTS) (2 arms), sponsored by Diakonhjemmet Sykehus. Started Oct 2021; status: active.
02
Drugs
triamcinolone hexacetonide
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on 2021-004756-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-004756-42.